We believe that the effects of these two NPSs are very relevant and confer a specific and real prediction risk, considering all the relevant clinical and biological factors accounted for in the statistical model (CSF AD-core biomarkers, APOE ε4 status and amnestic and probable MCI subtypes). This evidence concerns the gene APOE and Alzheimer disease.